Growth factors (affinity-based delivery)

Growth factors via affinity motifs within the delivery matrix refers to a sophisticated tissue engineering and drug delivery strategy designed to mimic the natural extracellular matrix (ECM). In this approach, biomaterial scaffolds—such as hydrogels or collagen sponges—are engineered with specific binding sites, including heparin-mimetic peptides or aptamers, that sequester growth factors like VEGF, BMP-2, or FGF through non-covalent interactions (Briquez et al., 2016, Nature Reviews Materials). This sequestration protects the growth factors from rapid enzymatic degradation and allows for a controlled, sustained release profile that is critical for effective tissue regeneration. By localizing growth factors at the site of injury and preventing a 'burst release,' this method enhances therapeutic efficacy while minimizing systemic side effects. This strategy is widely investigated for clinical applications in bone repair, chronic wound healing, and cardiovascular regeneration (Martino et al., 2014, Science). However, it is classified as a therapeutic delivery methodology rather than a single biological target molecule or receptor.

Other names

Affinity-based drug delivery systemsGrowth factor sequestering matricesExtracellular matrix-mimetic scaffoldsHeparin-binding delivery systemsGrowth factor delivery via affinity motifs

The mechanism involves the sequestration of growth factors within a synthetic or natural matrix using high-affinity motifs, such as heparin, specific peptides, or aptamers. This mimics the natural extracellular matrix (ECM) which uses heparan sulfate proteoglycans to store and protect growth factors from proteolytic degradation (Vulic & Shoichet, 2014, Biomacromolecules). By binding the growth factors non-covalently, the matrix provides a sustained and localized release, ensuring that the therapeutic proteins remain at the site of injury to trigger specific cellular signaling pathways for tissue repair while preventing the systemic toxicity associated with high-dose 'burst' releases (Martino et al., 2014, Science).